Cardinal Moves One Step Closer To Fee For Service With Third Manufacturer Contract
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler signed one more brand-name drug manufacturer to a fee-for-service distribution contract in November. McKesson is also moving to the new reimbursement model and believes it will complete most of its fee-for-service contracts by February.
You may also be interested in...
Cardinal Drug Distribution Fees From Lilly To Be “Performance Based”
Fee-for-service drug distribution contract with Lilly will pay Cardinal based on the wholesaler meeting predetermined service levels. Cardinal previously announced signing fee-for-service contracts with Merck and Gilead.
Cardinal Drug Distribution Fees From Lilly To Be “Performance Based”
Fee-for-service drug distribution contract with Lilly will pay Cardinal based on the wholesaler meeting predetermined service levels. Cardinal previously announced signing fee-for-service contracts with Merck and Gilead.
Cardinal Has Fee-For-Service Agreements With Two “Large” Manufacturers
Additional contracts have been signed with several “mid-tier” manufacturers, and three additional agreements with large manufacturers are expected in the next month. The wholesaler wants to switch 85% of its sales volume to fee-for-service.